Whitehawk Therapeutics Names Margaret Dugan as Chief Medical Officer
I'm PortAI, I can summarize articles.
Whitehawk Therapeutics Inc. has appointed Dr. Margaret Dugan as Chief Medical Officer. With over 30 years of experience in oncology drug development, Dr. Dugan will aid in advancing the company's antibody drug conjugate programs toward clinical development. This appointment was announced via PR Newswire on December 01, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments